Clinical Trials Browser

Terminated × Breast Neoplasms × Fluorodeoxyglucose F18 × Clear all

NCT03432741 2025-05-26

Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer

Phase 1 Terminated

BreastDermatologicLymphoid

Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone

NCT02810873 2025-05-04

Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer

Phase NA Terminated

19 enrolled 7 charts

Breast Neoplasms

NCT02317783 2024-11-20

Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment

Phase 2 Terminated

15 enrolled 6 charts

Breast Neoplasms

NCT01931709 2023-11-18

FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer

Phase NA Terminated

35 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT02149173 2021-06-30

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Phase NA Terminated

29 enrolled 9 charts

Breast Neoplasms

NCT01222416 2017-07-02

PET/CT Evaluation of Treatment Response in Breast Cancer

Phase NA Terminated

50 enrolled 6 charts

Breast Neoplasms